DiaMonTech GmbH, a young and innovative medical technology company has been nominated by EIT Digital, a leading European player in innovation and entrepreneurial education, as a finalist in its pan-European competition EIT Digital Challenge 2019. The competition focuses on startups in growth stage, so called scaleups, with deep tech products that leverage sophisticated, hard-to-reproduce technologies fueling the digital transformation.
"After winning the 'Start me up!' founder prize by BILANZ magazine in 2017, this is already the second renowned competition in which we have reached the final. In a field of nearly 300 participating start-ups, this is already a great distinction that gives us further impetus. With our ground-breaking method for non-invasive blood glucose monitoring, we are developing a product that many people have been waiting for," says Thorsten Lubinski, co-founder and CEO of DiaMonTech GmbH.
The participating companies from 12 European countries applied in five categories, strategically chosen with respect to major digital trends and European leadership potential: Digital Tech, Digital Industry, Digital Cities, Digital Finance and Digital Wellbeing. The finalists present their technology to an international expert jury of corporates and investors at the final event in Brussels on 6 November 2019.
DiaMonTech AG is a medical technology company that specializes in the development, design and sale of products for medical diagnostics. The patented photothermal diagnostic technology based on infrared lasers enables the precise measurement of relevant blood parameters. The first application is the non-invasive blood glucose measurement, which enables an accurate and fast measurement without pain.
More information about DiaMonTech can be found at www.diamontech.de.
Kirchhoff Consult AG
Phone +49 40 60 91 86 70